PALB2: A novel inactivating mutation in a Italian breast cancer family

Familial Cancer

Volumn 9, Issue 4, 2010, Pages 531-536

  Balia, Cristina ^a   Sensi, Elisa ^a   Lombardi, Grazia ^a   Roncella, Manuela ^a   Bevilacqua, Generoso ^b   Caligo, Maria Adelaide ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

BRCA1, BRCA2; BRCA1 BRCA2 negative families; Breast cancer risk; Breast cancer susceptibility; PALB2

Indexed keywords

BRCA1 PROTEIN; PARTNER AND LOCALIZER OF BRCA2 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; EXON; FAMILIAL CANCER; FRAMESHIFT MUTATION; GENE MUTATION; HIGH RISK POPULATION; HUMAN; ITALY; MUTATIONAL ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROTEIN FUNCTION; STOP CODON;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ITALY; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PEDIGREE; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 78650201265     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-010-9382-1     Document Type: Article

References (19)

1. B Xia Q Sheng K Nakanishi A Ohashi J Wu N Christ X Liu M Jasin FJ Couch DM Livingston 2006 Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2 Mol Cell 22 6 719 729 1:CAS:528:DC%2BD28XmvVCitL8%3D 10.1016/j.molcel.2006.05.022 16793542
2. N Rahman S Seal D Thompson P Kelly A Renwick A Elliott S Reid K Spanova R Barfoot T Chagtai H Jayatilake L McGuffog S Hanks DG EVans D Eccles DF Easton MR Stratton 2007 PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nat Genet 39 2 165 167 1:CAS:528: DC%2BD2sXpvFeqsw%3D%3D 10.1038/ng1959 17200668 (Pubitemid 46184346)
3. H Erkko B Xia J Nikkila J Schleutker K Syrjakoski A Mannermaa A Kallioniemi K Pylkas SM Karppinen K Rapakko A Miron Q Sheng G Li H Mattila DW Bell DA Haber M Grip M Reiman A Jukkola-Vuorinen A Mustonen J Kere LA Aaltonen VM Kosma V Kataja Y Soini RI Drapkin DM Livingston R Winqvist 2007 A recurrent mutation in PALB2 in Finnish cancer families Nature 446 7133 316 319 1:CAS:528:DC%2BD2sXivVSns78%3D 10.1038/nature05609 17287723 (Pubitemid 46426155)
4. B Xia JC Dorsman N Ameziane Y de Vries MA Rooimans Q Sheng G Pals A Errami E Gluckman J Llera W Wang DM Livingston H Joenje JP de Winter 2007 Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 Nat Genet 39 2 159 161 1:CAS:528:DC%2BD2sXpvFekug%3D%3D 10.1038/ng1942 17200672 (Pubitemid 46184344)
5. S Reid D Schindler H Hanenberg K Barker S Hanks R Kalb K Neveling P Kelly S Seal M Freund M Wurm SD Batish FP Lach S Yetgin H Neitzel H Ariffin M Tischkowitz CG Mathew AD Auerbach N Rahman 2007 Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer Nat Genet 39 2 162 164 1:CAS:528:DC%2BD2sXpvFersA%3D%3D 10.1038/ng1947 17200671 (Pubitemid 46184345)
6. K Offit O Levran B Mullaney K Mah K Nafa SD Batish R Diotti H Schneider A Deffenbaugh T Scholl VK Proud M Robson L Norton N Ellis H Hanenberg AD Auerbach 2003 Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia J Natl Cancer Inst 95 20 1548 1551 1:CAS:528:DC%2BD3sXosVertbk%3D 14559878 (Pubitemid 37322099)
7. B Hirsch A Shimamura L Moreau S Baldinger M Hag-alshiekh B Bostrom S Sencer AD D'Andrea 2004 Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood Blood 103 7 2554 2559 1:CAS:528:DC%2BD2cXjtVaksr0%3D 10.1182/blood-2003-06-1970 14670928 (Pubitemid 38393006)
8. JE Wagner J Tolar O Levran T Scholl A Deffenbaugh J Satagopan L Ben-Porat K Mah SD Batish DI Kutler ML MacMillan H Hanenberg AD Auerbach 2004 Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia Blood 103 8 3226 3229 1:CAS:528: DC%2BD2cXjsVagsbo%3D 10.1182/blood-2003-09-3138 15070707 (Pubitemid 38451703)
9. F Zhang Q Fan K Ren PR Andreassen 2009 PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2 Mol Cancer Res 7 7 1110 1118 1:CAS:528:DC%2BD1MXos1emtrc%3D 10.1158/1541-7786.MCR-09-0123 19584259
10. T Hayakawa F Zhang N Hayakawa Y Ohtani K Shinmyozu J Nakayama PR Andreassen 2010 MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks J Cell Sci 123 Pt 7 1124 1130 1:CAS:528: DC%2BC3cXmsF2qsL8%3D 10.1242/jcs.060178 20332121
11. M Tischkowitz B Xia N Sabbaghian JS Reis-Filho N Hamel G Li EH Van Beers L Li T Khalil LA Quenneville A Omeroglu A Poll P Lepage N Wong PM Nederlof A Ashworth PN Tonin SA Narod DM Livingston WD Foulkes 2007 Analysis of PALB2/FANCN-associated breast cancer families Proc Natl Acad Sci U S A 104 16 6788 6793 1:CAS:528:DC%2BD2sXkvFWjtrk%3D 10.1073/pnas.0701724104 17420451 (Pubitemid 47175579)
12. H Gunnarsson A Arason EM Gillanders BA Agnarsson G Johannesdottir OT Johannsson RB Barkardottir 2008 Evidence against PALB2 involvement in Icelandic breast cancer susceptibility J Negat Results Biomed 7 5 10.1186/1477-5751-7-5 18637200
13. JH Kim DH Choi DY Cho SH Ahn BH Son 2010 Haffty BG PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations Breast Cancer Res Treat 122 1 303 306 1:CAS:528:DC%2BC3cXntlKlsL8%3D 10.1007/s10549-010-0806-2 20213081
14. WD Foulkes P Ghadirian MR Akbari N Hamel S Giroux N Sabbaghian A Darnel R Royer A Poll E Fafard A Robidoux G Martin TA Bismar M Tischkowitz F Rousseau SA Narod 2007 Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women Breast Cancer Res 9 6 R83 10.1186/bcr1828 18053174
15. A Dansonka-Mieszkowska A Kluska J Moes M Dabrowska D Nowakowska A Niwinska P Derlatka K Cendrowski J Kupryjanczyk 2010 A novel germline PALB2 deletion in Polish breast and ovarian cancer patients BMC Med Genet 11 20 10.1186/1471-2350-11-20 20122277
16. L Papi AL Putignano C Congregati I Piaceri I Zanna F Sera D Morrone M Genuardi D Palli 2009 A PALB2 germline mutation associated with hereditary breast cancer in Italy Fam Cancer 9 2 181 185 10.1007/s10689-009-9295-z 19763884
17. H Erkko JG Dowty J Nikkila K Syrjakoski A Mannermaa K Pylkas MC Southey K Holli A Kallioniemi A Jukkola-Vuorinen V Kataja VM Kosma B Xia DM Livingston R Winqvist JL Hopper 2008 Penetrance analysis of the PALB2 c.1592delT founder mutation Clin Cancer Res 14 14 4667 4671 1:CAS:528:DC%2BD1cXosFGiur0%3D 10.1158/1078-0432.CCR-08-0210 18628482
18. MJ Garcia V Fernandez A Osorio A Barroso G Llort C Lazaro I Blanco T Caldes M de la Hoya YCT Ramon C Alonso MI Tejada C San Roman L Robles-Diaz M Urioste J Benitez 2009 Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families Breast Cancer Res Treat 113 3 545 551 1:CAS:528:DC%2BD1MXotValsg%3D%3D 10.1007/s10549-008-9945-0 18302019
19. W Wang 2007 Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins Nat Rev Genet 8 10 735 748 1:CAS:528:DC%2BD2sXhtVCrsb3J 10.1038/nrg2159 17768402 (Pubitemid 47429206)